Professor David J. Grieve is a Professor at the School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast. After being awarded a BSc Honours Degree by the University of Dundee (1995), he completed a PhD focussed on dietary lipoproteins and atherosclerosis at The Royal Veterinary College, University of London (1998). Then, he worked as a PDRA in the Cardiovascular Division at King's College London until 2005, when he took up an academic position within the School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast, where he is currently a full Professor leading an established research program and also Faculty Dean. His fields of interest include cardiovascular biology; pathophysiology; and pharmacology. His research program is focussed on investigating mechanisms underlying cardiovascular disease and heart failure, with a particular interest in the influence of oxidative stress and diabetes. Notable achievements include receipt of the International Society for Heart Research Young Investigator Award (2003) and a prestigious Medical Research Council UK New Investigator Research Grant (2007), as well as election to the committee of the British Society for Cardiovascular Research (2008) on which he served as Honorary Secretary (2014–2020).
Professor David J. Grieve is a Professor at the School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast. After being awarded a BSc Honours Degree by the University of Dundee (1995), he completed a PhD focussed on dietary lipoproteins and atherosclerosis at The Royal Veterinary College, University of London (1998). Then, he worked as a PDRA in the Cardiovascular Division at King's College London until 2005, when he took up an academic position within the School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast, where he is currently a full Professor leading an established research program and also Faculty Dean. His fields of interest include cardiovascular biology; pathophysiology; and pharmacology. His research program is focussed on investigating mechanisms underlying cardiovascular disease and heart failure, with a particular interest in the influence of oxidative stress and diabetes. Notable achievements include receipt of the International Society for Heart Research Young Investigator Award (2003) and a prestigious Medical Research Council UK New Investigator Research Grant (2007), as well as election to the committee of the British Society for Cardiovascular Research (2008) on which he served as Honorary Secretary (2014–2020).